AstraZeneca and Daiichi Sankyo's Enhertu receives US priority review for post-neoadjuvant HER2-positive early breast cancer

Ipsen withdraws tazverik across all markets following safety concerns in lymphoma trial

GSK licences global rights to linerixibat to Alfasigma in USD300m deal

IDEAYA Biosciences enrols first patient in Phase 1 trial of PRMT5 inhibitor IDE892

Halozyme reports US FDA approval of TECVAYLI in combination with DARZALEX FASPRO for relapsed/refractory multiple myeloma

Servier signs definitive agreement with Day One Biopharmaceuticals

PureHealth Research launches new natural GLP-1 supplements

PyroGenesis completes plasma torch system for Constellium aluminium furnace project

Great Novel Therapeutics' GNTbm-38 approved by US FDA for Phase I trial

Elicera Therapeutics reports complete metabolic responses in highest‑dose CARMA cohort

Johnson & Johnson reports US FDA approval of TECVAYLI plus DARZALEX FASPRO for RRMM

Thermo Fisher Scientific opens Bay Area cryo-EM Drug Discovery Center

GAIA and Daiichi Sankyo Europe partner on digital therapeutic for cardiovascular care

iLoF collaborates with Bluepharma to deploy AI-powered Optomics

Akeso agrees clinical trial collaboration with INOVIO